PLATFORM
TEAM
MEDIA
PARTNERSHIP
CAREER
CONTACT
IN THE MEDIA
Strand Therapeutics targeting solid tumors with with its MIT born technology
Strand Therapeutics on its Bristol-Myers Squibb LabCentral Golden Ticket Win
Forbes
Declaring War on Infectious Disease: The Case For A Vaccine Manhattan Project
Boston Globe
Mixed reactions as Moderna says it will offer vaccine to employees, board members, and their households
Forbes
From Here To Cured: What Will Post-Pandemic Biotech Look Like?
In Vivo
Lessons From Biotech Entrepreneurs: Pitching Your First-In-Class Innovation
OZY
The Man Delivering Covid Vaccines to Poorer Nations
BioSpace
Strand Therapeutics’ mRNA Logic Circuits Enhance Gene Therapy’s Safety, Ease and Controllability
Medium
Becoming a Post-Pandemic Species
The Coronavirus Pandemic
Coronavirus: in search for vaccine, US small firms take a leading role
Med City News
Among Covid-19 vaccine technologies, mRNA represents faster, easier approach, some experts say
Merger Market
Global biotech and pharma leverage pipelines for COVID-19, but no quick win solutions - Analysis
Business Wire
Dr. Dane Wittrup & Dr. Mark Frohlich Join Strands Advisory Board
MIT Technology Review
A coronavirus vaccine will take at least 18 months—if it works at all
Medium
Strand Therapeutics — Genetically Programming mRNA
Boston Business Journal
MIT gene-therapy spinout raises $6M
Bloomberg
$6 Million Seed Financing to Advance its Programmable mRNA
FinSME
Strand Therapeutics Raises $6M in Seed Funding
BIOCENTURY
Strand’s smart mRNA
Fierce Biotech
Improving cancer immunotherapy by controlling RNA expression
GEN Edge
RNA-Based Gene Therapy Can Be Turned ON or OFF via Synbio Switches
MIT News
This RNA-based technique could make gene therapy more effective